ATS 2019 Virtual Final Program

Chairing: S.M. Jamil, MD, ATSF, La Jolla, CA J.A. Cooksey, MD, Chicago, IL 2:15 Circadian Disorders: Advanced, Delayed, Non-24 C.A. Goldstein, MD, MS, Ann Arbor, MI 2:45 Circadian Disorders: Shift Work, Jet Lag R. Auger, MD, Rochester, MN 3:15 Sleep in High-Risk Populations K.A. Dudley, MD, MPH, Cambridge, MA 3:45 Update on Pediatric Sleep M. Chen, MD, Seattle, WA CLINICAL CLINICAL TOPICS IN PULMONARY MEDICINE CME Credits Available: 2 MOC Points Available: 2 C82 CHALLENGES IN THE LONG-TERM CLINICAL MANAGEMENT OF SARCOIDOSIS Assemblies on Clinical Problems; Allergy, Immunology and Inflammation 2:15 p.m. - 4:15 p.m. KBHCCD Ballroom C One-Two (Level 2) Target Audience Providers who see patients with sarcoidosis and other interstitial lung diseases Objectives At the conclusion of this session, the participant will be able to: • appropriately utilise long term surveillance assessments for sarcoidosis; • become better equipped to utilise non-steroidal treatments in the long-term management of sarcoidosis; • improve the quality of life of patients with sarcoidosis by focusing on the common but non-organ-specific symptoms of fatigue, depression and pain. Most clinicians feel comfortable initiating systemic corticosteroids in newly diagnosed patients with symptomatic or organ-threatening sarcoidosis. Yet, most feel ill equipped for long-term clinical management. This includes how to communicate the long-term treatment and screening roadmap to patients. This symposium will address key areas of long-term management, including guidance on how to recognise and treat recurrent disease, how and when to add corticosteroid-sparing immunosuppressive therapies, and how to assess for and manage systemic symptoms, such as fatigue, which are common and often debilitating in sarcoidosis. Chairing: A.S. Morgenthau, MD, New York, NY W.P. Drake, MD, Nashville, TN 2:15 Introduction to Sarcoidosis Pathogenesis E.S. Chen, MD, Baltimore, MD 2:35 A Patient's Perspective S. Detter,Frisco, TX 2:40 Disease Recurrence and Exacerbations K.C. Patterson, MD, Falmer, United Kingdom 2:59 Beyond Steroids: What to Use and How They Work W.P. Drake, MD, Nashville, TN 3:18 Fighting Fatigue and Other Systemic Symptoms in Sarcoidosis M. Gering-Voortman, MD, Maastricht, Netherlands 3:37 Screening for Silent Disease: How Far Do We Have to Go M.A. Judson, MD, Albany, NY 3:56 The Road to Eternity: How to Explain a Chronic Disease to Patients M.S. Balter, MD, Toronto, Canada This session and the International Conference are supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals. All CME sessions have been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) and are free of the control of commercial interests. CLINICAL CLINICAL TOPICS IN PULMONARY MEDICINE CME Credits Available: 2 MOC Points Available: 2 C83 PEDIATRIC CLINICAL CHEST ROUNDS Assembly on Pediatrics 2:15 p.m. - 4:15 p.m. OMNI DALLAS DOWNTOWN Dallas Ballroom A-C (Level 3) Target Audience Pediatric pulmonary clinicians, including physicians, NPs, nurses, and other health professionals interested in the diagnosis and management of challenging pediatric cases Objectives At the conclusion of this session, the participant will be able to: • generate a broad differential diagnosis for challenging cases in pediatric pulmonary medicine; • apply current diagnostic testing to the management of challenging cases in pediatric pulmonary medicine; • discuss state of the art management of challenging pediatric pulmonary cases. Pediatric Clinical Chest Rounds focuses on the diagnosis and management of 4 challenging clinical cases selected from the case reports submitted to the Pediatric Assembly. Each case is presented by a trainee (usually a pediatric pulmonary fellow) and discussion is led by an expert in the field. Chairing: J. Needleman, MD, Brooklyn, NY A.G. Filbrun, MD, MS, Ann Arbor, MI A.R. O'Hagan, MD, Louisville, KY 2:15 Adolescent with Rapid Onset of Respiratory Failure J. Kaslow, MD, Nashville, TN 2:40 Expert Discussant T. Moraes, MD, Toronto, ON, Canada 2:45 Cough and Cystic Masses in a 2 Month Old J. Maniaci, MD, Nashville, TN 3:10 Expert Discussant A.E. Stone, MD, Portland, OR 3:15 Emphysema and Exertional Dyspnea B. Bartley, MD, Boston, MA 3:40 Expert Discussant M. Schecter, Cincinnati, OH ATS 2019 • Dallas, TX TUESDAY • MAY 21 291 TUESDAY AFTERNOON